Testosterone supplementation therapy (TST) is a widely used treatment for men with late onset hypogonadism.
The benefits seen with TST, such as improved libido and energy level, beneficial effects on bone density have been well documented. Although hypogonadism remains an independent risk factor for mortality, recent studies have examined the association between testosterone therapy and cardiovascular risk.
Written by:
Ramasamy R, Dupree JM, Kovac JR, Lipshultz LI. Are you the author?
Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA.
Reference: F1000Res. 2014 Jan 15;3:11.
doi: 10.12688/f1000research.3-11.v1
PubMed Abstract
PMID: 24555118
UroToday.com Androgen Deficiency Section
